Table 2.
Effect of spirulina consumption on other markers of cardiovascular disease
| Markers outcomes | No. of treatment arms | No. of patients | WMD (95% CI) | P-value | I2, % |
|---|---|---|---|---|---|
|
| |||||
| vLDL-C (mg/dL) | 5 | 167 | −8.02 (−8.77 to −7.26) | 0.0001* | 0 |
| FBG (mg/dL) | 8 | 411 | −5.01 (−9.78 to −0.24) | 0.04* | 51 |
| HbA1c | 3 | 82 | −0.34 (−0.79 to 0.11) | 0.14 | 78 |
| SBP (mmHg) | 4 | 141 | −3.49 (−7.19 to 0.21) | 0.06 | 50 |
| DBP (mmHg) | 4 | 141 | −7.17 (−8.57 to −5.78) | 0.0001* | 0 |
| Body weight (kg) | 7 | 276 | −1.51 (−3.39 to 0.36) | 0.11 | 0 |
| BMI (kg/m2) | 5 | 354 | −0.44 (−1.87 to 0.99) | 0.54 | 71 |
Notes:
*
Indicates a significant result.
Abbreviations: BMI, body mass index; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; vLDL-C, very-low-density cholesterol; WMD, weighted mean differences.